Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy

Stanic, Karmen; Vrankar, Martina; But-Hadzic, Jasna

doi:10.2478/raon-2020-0046

References

van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet 2011; 378: 1741-55. doi: 10.1016/S0140-6736(11)60165-7
Open DOI Search in Google Scholar Back to article
Cancer in Slovenia 2014. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2017.
Search in Google Scholar Back to article
Mitchell MD, Aggarwal C, Tsou AY, Torigian DA, Treadwell JR. Imaging for the pretreatment staging of small cell lung cancer: a systematic review. Acad Radiol 2016; 23: 1047-56. doi: 10.1016/j.acra.2016.03.017
Open DOI Search in Google Scholar Back to article
Niho S, Fujii H, Murakami K, Nagase S, Yoh K, Goto K, et al. Detection of unsuspected distant metastases and/or regional nodes by FDG-PET [corrected] scan in apparent limited-disease small-cell lung cancer. Lung Cancer 2007; 57: 328-33. 10.1016/j.lungcan.2007.04.001
Open DOI Search in Google Scholar Back to article
Früh M, De Ruysscher D, Popat S, Crinò L, Peters S, Felip E, on behalf of the ESMO Guidelines Working Group. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24(Suppl 6): vi99-105. doi: 10.1093/annonc/mdt178
Open DOI Search in Google Scholar Back to article
National Comprehensive Cancer Network. NCCN guidelines version 2.2020. Small cell lung cancer Nov 15 2019. [Cited 2020 Feb 15]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/sclc.pdf
Search in Google Scholar Back to article
Slotman B, Faivre-Finn C, Kramer G, Rankin E, Snee M, Hatton M, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007; 357: 664-72. doi: 10.1056/NEJMoa071780
Open DOI Search in Google Scholar Back to article
Slotman BJ, van Tinteren H, Praag JO, Knegjens JL, El Sharouni SY5 Hatton M, et al. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Lancet 2015; 385: 36-42. doi: 10.1016/S0140-6736(14)61085-0
Open DOI Search in Google Scholar Back to article
Gore EM, Hu C, Sun AY, Grimm DF, Ramalingam SS, Dunlap NE, et al. Randomized phase II study comparing prophylactic cranial irradiation alone to prophylactic cranial irradiation and consolidative extracranial irradiation for extensive-disease small cell lung cancer (ED SCLC): NRG Oncology RTOG 0937. J Thorac Oncol 2017; 12: 1561-70. doi: 10.1016/j.jtho.2017.06.015
Open DOI Search in Google Scholar Back to article
Zhu H, Zhou Z, Wang Y, Bi N, Feng Q, Li J, et al. Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis. Cancer 2011; 117: 5423-31. doi: 10.1002/cncr.26206
Open DOI Search in Google Scholar Back to article
Yee D, Butts C, Reiman A, Joy A, Smylie M, Fenton D, et al. Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer. Radiother Oncol 2012; 102: 234-8. doi: 10.1016/j.radonc.2011.08.042
Open DOI Search in Google Scholar Back to article
Giuliani ME, Atallah S, Sun A, et al. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy. Clin Lung Cancer 2011; 12: 375-9. doi: 10.1016/j.cllc.2011.03.028
Open DOI Search in Google Scholar Back to article
Zhang R, Li P, Li Q, Qiao Y, Xu T, Ruan P, et al. Radiotherapy improves the survival of patients with extensive-disease small-cell lung cancer: a propensity score matched analysis of surveillance, epidemiology, and end results database. Cancer Manag Res 2018; 10: 6525-35. doi: 10.2147/CMAR.S174801
Open DOI Search in Google Scholar Back to article
Jeremic B, Gomez-Caamano A, Dubinsky P, Cihoric N, Casas F, Filipovic N. Radiation therapy in extensive stage small cell lung cancer. Front Oncol 2017; 7: 169. doi: 10.3389/fonc.2017.00169
Open DOI Search in Google Scholar Back to article
Alvarado-Luna G, Morales-Espinosa D. Treatment for small cell lung cancer, where are we now?-a review. Transl Lung Cancer Res 2016; 5: 26-38. doi: 10.3978/j.issn.2218-6751.2016.01.13.
Open DOI Search in Google Scholar Back to article
Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, et al. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med 2018; 379: 2220-9. doi: 10.1056/NEJMoa1809064
Open DOI Search in Google Scholar Back to article
Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, et al. Durvalumab plus platinum–etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Lancet 2019; 394: 1929-39. doi: 10.1016/S0140-6736(19)32222-6
Open DOI Search in Google Scholar Back to article
Jeremic B, Shibamoto Y, Nikolic N, Milicic B, Milisavljevic S, Dagovic A, et al. Role of radiation therapy in the combined modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol 1999; 17: 2092-9. doi: 10.1200/JCO.1999.17.7.2092
Open DOI Search in Google Scholar Back to article
Palma DA, Warner A, Louie AV, Senan S, Slotman B, Rodrigues GB. Thoracic radiotherapy for extensive stage small-cell lung cancer: a meta-analysis. Clin Lung Cancer 2016; 17: 239-44. doi: 10.1016/j.cllc.2015.09.00
Open DOI Search in Google Scholar Back to article
Rathod S, Jeremic B, Dubey A, Giuliani M, Bashir B, Chowdhury A, et al. Role of thoracic consolidation radiation in extensive stage small cell lung cancer: A systematic review and meta-analysis of randomised controlled trials. Eur J Cancer 2019; 110: 110-9. doi: 10.1016/j.ejca.2019.01.003
Open DOI Search in Google Scholar Back to article
Xu LM, Zhao LJ, Charles B , Simone CB 2nd, Cheng C, Kang M, et al. Receipt of thoracic radiation therapy and radiotherapy dose are correlated with outcomes in a retrospective study of three hundred and six patients with extensive stage small-cell lung cancer. Radiother Oncol 2017; 125: 331-7. doi: 10.1016/j.radonc.2017.10.005
Open DOI Search in Google Scholar Back to article
Hasan S, Renz P, Turrisi A, Colonias A, Finley G, Wegner RE. Dose escalation and associated predictors of survival with consolidative thoracic radiotherapy in extensive stage small cell lung cancer (SCLC): A National Cancer Database (NCDB) propensity-matched analysis. Lung Cancer 2018; 124: 283-90. doi: 10.1016/j.lungcan.2018.08.016
Open DOI Search in Google Scholar Back to article
Xu LM, Cheng C, Kang M, Luo J, Gong LL, Pang QS, et al. Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer. Sci Rep 2017; 7: 9255. doi: 10.1038/s41598-017-09775-0
Open DOI Search in Google Scholar Back to article
Fukui T, Itabashi M, Ishihara M, Hiyoshi Y, Kasajima M, Igawa S, et al. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer. BMC Cancer 2016; 16: 197. doi:10.1186/s12885-016-2222-4
Open DOI Search in Google Scholar Back to article
Luo J, Xu L, Zhao L, Cao Y, Pang Q, Wang J, et al. Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not? Radiat Oncol 2017; 12: 42. doi: 10.1186/s13014-017-0779-y
Open DOI Search in Google Scholar Back to article
De Ruysscher D, Lueza B, Le Péchoux C, Johnson DH, O’Brien M, Murray N, et al. Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis. Ann Oncol 2016; 27: 1818-28. doi: 10.1093/annonc/mdw263
Open DOI Search in Google Scholar Back to article
Stanic K, Kovac V. Prophylactic cranial irradiation in patients with small-cell lung cancer: the experience at the Institute of Oncology Ljubljana. Radiol Oncol 2010; 44: 180-6. doi: 10.2478/v10019-010-0038-4
Open DOI Search in Google Scholar Back to article
Takahashi T, Yamanaka T, Seto T, Harada H, Nokihara H, Saka H, et al. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 2017; 18: 663-71. doi: 10.1016/S1470-2045(17)30230-9
Open DOI Search in Google Scholar Back to article
Rusthoven CG, Kavanagh BD. Prophylactic cranial irradiation (PCI) versus active MRI surveillance for small cell lung cancer: the case for equipoise. J Thorac Oncol 2017; 12: 1746-54. doi: 10.1016/j.jtho.2017.08.016
Open DOI Search in Google Scholar Back to article
Hui R, Gandhi L, Costa EC, Felip E, Ahn MJ, Eder JP, et al. Long-term OS for patients with advanced NSCLC enrolled in the KEYNOTE-001 study of pembrolizumab (pembro). J Clin Oncol 2016; 34: Abstr nr 9026.
Search in Google Scholar Back to article
Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, et al. Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med 2015; 372: 2018-28. doi: 10.1056/NEJMoa1501824
Open DOI Search in Google Scholar Back to article
Herbst RS, Baas P, Kim DW, Felip E, Pérez-Gracia JL, Han JY, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet 2016; 387: 1540-50. doi: 10.1016/S0140-6736(15)01281-7
Open DOI Search in Google Scholar Back to article
Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med 2016; 375: 1823-33. doi: 10.1056/NEJMoa1606774
Open DOI Search in Google Scholar Back to article
Langer CJ, Gadgeel SM, Borghaei H, Papadimitrakopoulou VA, Patnaik A, Powell SF, et al. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. Lancet Oncol 2016; 17: 1497-508. doi: 10.1016/S1470-2045(16)30498-3
Open DOI Search in Google Scholar Back to article
Brahmer J, Reckamp KL, Baas P, Crinò L, Eberhardt WE, Poddubskaya E, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med 2015; 373: 123-35. doi: 10.1056/NEJMoa1504627
Open DOI Search in Google Scholar Back to article
Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med 2015; 373: 1627-39. doi: 10.1056/NEJMoa1507643
Open DOI Search in Google Scholar Back to article
Fehrenbacher L, Spira A, Ballinger M, Kowanetz M, Vansteenkiste J, Mazieres J, et al. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Lancet 2016; 387: 1837-46. doi: 10.1016/S0140-6736(16)00587-0
Open DOI Search in Google Scholar Back to article
Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, et al. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. N Engl J Med 2018; 379: 2342-50. doi: 10.1056/NEJMoa1809697
Open DOI Search in Google Scholar Back to article
Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, et al. Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer. N Engl J Med 2017; 377: 1919-29. doi: 10.1056/NEJMoa1709937
Open DOI Search in Google Scholar Back to article
Verma V, Cushman TR, Selek U, Tang C, Welsh JW. Safety of Combined Immunotherapy and Thoracic Radiation Therapy: Analysis of 3 Single-Institutional Phase I/II Trials. Int J Radiat Oncol Biol Phys 2018; 101: 1141-8. doi: 10.1016/j.ijrobp.2018.04.054
Open DOI Search in Google Scholar Back to article
Demaria S, Golden EB, Formenti SC. Role of local radiation therapy in cancer immunotherapy. JAMA Oncol 2015; 1: 1325-32. doi: 10.1001/jamaoncol.2015.2756
Open DOI Search in Google Scholar Back to article
Vrankar M, Stanic K. Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy. Radiol Oncol 2018; 52: 281-8. doi: 10.2478/raon-2018-0009
Open DOI Search in Google Scholar Back to article
Sharabi AB, Lim M, DeWeese TL, Drake CG. Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy. Lancet Oncol 2015; 16: e498-509. doi: 10.1016/S1470-2045(15)00007-8
Open DOI Search in Google Scholar Back to article

Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy

References

Paradigm

My account